Brief: Halozyme Therapeutics Says If Deal Is Terminated Under Certain Circumstances, Co To Pay Elektrofi Reverse Termination Fee Of $36 Million
03/10/2025 21:56
Oct 3 (Reuters) - Halozyme Therapeutics Inc HALO.O: HALOZYME THERAPEUTICS : IF DEAL IS TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY ELEKTROFI REVERSE TERMINATION FEE OF $36 MILLION Source text: [ID:n0001193125-25-230348] Further company coverage: HALO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Halozyme Therapeutics
See all newsUS RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Halozyme wins court order to block Merck's injected Keytruda in select European markets (updated)
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
Halozyme wins court order to block Merck's injected Keytruda in select European markets